Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
05/2010
05/18/2010CA2387536C Rate-controlled particles
05/15/2010CA2738671A1 Methods for preparing oxazolidinones and compositions containing them
05/14/2010WO2010054398A1 Compounds useful as inhibitors of atr kinase
05/14/2010WO2010054279A1 Compounds for the treatment of inflammatory disorders
05/14/2010WO2010054215A1 Methods of synthesis of benzazepine derivatives
05/14/2010WO2010054067A1 Gamma secretase modulators
05/14/2010WO2010054006A1 Modulators of cxcr7
05/14/2010WO2010054003A2 Methylindazole modulators of 5-ht3 receptors
05/14/2010WO2010053861A2 Biologically active amides
05/14/2010WO2010053583A2 Small molecule cd4 mimetics and uses thereof
05/14/2010WO2010053438A1 Modulators of amyloid beta.
05/14/2010WO2010053182A1 Kynurenine production inhibitor
05/14/2010WO2010052625A1 Pyrrolidines
05/14/2010WO2010052569A2 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
05/14/2010WO2010052448A2 Fused pyrazine derivatives as kinase inhibitors
05/14/2010WO2010052256A1 Melanocortin receptor antagonist compounds, process for preparing them and use thereof in human medicine and cosmetics
05/14/2010WO2010052255A1 Melanocortin receptor modulators, process for preparing them and use thereof in human medicine and cosmetics
05/14/2010WO2010052253A1 Oxoazetidine derivatives, process for the preparation thereof and use thereof in human medicine and in cosmetics
05/14/2010WO2010051781A1 Kinase inhibitors and their use as pharmaceutical agents
05/14/2010WO2010023473A3 Crystalline form of sunitinib and processes for its preparation
05/14/2010WO2010019210A3 Halofuginone analogs for inhibition of trna synthetases and uses thereof
05/14/2010WO2010009405A3 Targeted nitroxide agents
05/14/2010WO2010005572A3 Alpha-keto heterocycles as faah inhibitors
05/14/2010CA2743134A1 Compounds useful as inhibitors of atr kinase
05/14/2010CA2742897A1 Modulators of amyloid beta.
05/14/2010CA2742863A1 Methods of synthesis of benzazepine derivatives
05/14/2010CA2742602A1 Gamma secretase modulators
05/14/2010CA2741990A1 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
05/14/2010CA2741589A1 Pyrrolidines
05/14/2010CA2738785A1 Oxoazetidine derivatives, process for the preparation thereof and use thereof in human medicine and in cosmetics
05/14/2010CA2738749A1 Melanocortin receptor antagonist compounds, process for preparing them and use thereof in human medicine and cosmetics
05/14/2010CA2738584A1 Melanocortin receptor modulators, process for preparing them and use thereof in human medicine and cosmetics
05/13/2010US20100121074 Cyclic guanidine ionic liquid
05/13/2010US20100121072 Candesartan cilexetil polymorphs
05/13/2010US20100121055 Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof
05/13/2010US20100121049 Indenoisoquinolinone analogs and methods of use thereof
05/13/2010US20100121048 Cyclic Amine Compound and Use Thereof for the Prophylaxis or Treatment of Hypertension
05/13/2010US20100120838 Compounds for the treatment of inflammatory disorders
05/13/2010US20100120806 Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities
05/13/2010US20100120802 Novel Anti-Inflammatory and Analgesic Heterocyclic Amidines that Inhibit Nitrogen Oxide (NO) Production
05/13/2010US20100120800 Agent for preventing recurrence of cerebrovascular disorder and agent for ameliorating troubles following cerebrovascular disorder and inhibiting progress thereof
05/13/2010US20100120786 Piperazine Derivatives
05/13/2010US20100120784 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
05/13/2010US20100120783 Melanocortin receptor agonists
05/13/2010US20100120781 Novel Compounds for Treatment of Cancer and Disorders Associated with Angiogenesis Function
05/13/2010US20100120779 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands
05/13/2010US20100120771 Aurora kinase inhibitors from an encoded small molecule library
05/13/2010US20100120769 Cyclohexyl piperazinyl methanone derivatives
05/13/2010US20100120749 Tetrahydroindole derivatives as nadph oxidase inhibitors
05/13/2010US20100120719 Lyophilization formulation
05/13/2010US20100120714 Substituted benzene fungicides
05/13/2010US20100119475 Novel inhibitors of glutaminyl cyclase
05/12/2010EP2184283A1 Process for preparing compounds useful as intermediates for the preparation of modulators of chemokine receptor activity
05/12/2010EP2184282A1 Novel salt of isoquinoline compound and crystal thereof
05/12/2010EP2184272A1 Piperazine derivative
05/12/2010EP2183244A1 Crystalline form of methyl ((1s)-1-(((2s)-2-(5-(4'-(2-((2s)-1-((2s)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1h-imidazol-5-yl)-4-biphenylyl)-1h-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate dihydrochloride salt
05/12/2010EP2183243A2 Pyrazole compounds and their use as raf inhibitors
05/12/2010EP2183227A1 1, 2, 4 -triazole derivatives as serotonergic modulators
05/12/2010EP2182953A2 New pyrazol derivatives
05/12/2010EP2076499B1 Pyrazine-2-carboxamide derivatives as cb2 receptor modulators
05/12/2010EP2066318B1 Oxindole derivatives as anticancer agents
05/12/2010EP2049519B1 Cyclic derivatives as modulators of chemokine receptor activity
05/12/2010EP1173169B1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
05/12/2010CN1867336B 1-aryl-4-substituted piperazines derivatives and pharmaceutical use thereof
05/12/2010CN1713908B Aminoalkoxyindoles as 5-HT6-receptor ligands for the treatment of CNA-disorders
05/12/2010CN1642552B 4-(N-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors
05/12/2010CN101707863A protein kinase inhibitors and methods for using thereof
05/12/2010CN101704812A Azasugar compounds and preparation method and application thereof
05/12/2010CN101704797A compounds effecting glucokinase
05/12/2010CN101475565B Anti-hypertension compound, and preparation, pharmaceutical composition and use thereof
05/12/2010CN101153458B Optical bleaching agent for phthalocyanines, preparation and application thereof
05/12/2010CN101027290B Novel 2,3-phthalazinone derivatives, as AURORA-A kinase inhibitors
05/11/2010US7714319 Organic thin film transistor
05/11/2010US7714143 Method of making monoammonium salt of 5,5′-bis-1H-tetrazole
05/11/2010US7714130 To a suspension of 2-(4-t-butylphenyl)-4-piperazin-1-yl-1H-benzimidazole and potassium carbonate in acetone was added 6-bromomethylquinoxaline to produce 2-(4-tert-butylphenyl)4-{[4-(6-quinoxalyl)methyl]piperazin-1-yl}benzimidazole Dihydrochloride Dihydrate
05/11/2010US7714019 Indole, azaindole and related heterocyclic pyrrolidine derivatives
05/11/2010US7714013 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
05/11/2010US7714009 Nitrogen-containing fused heterocyclic compounds
05/11/2010US7714001 Arylvinylazacycloalkane compounds and methods of preparation and use thereof
05/11/2010US7713987 N2-Chlorocarbonyl-N4-(2,2-dimethyl-3-oxo-4H-5-pyrido[1,4]oxazin-6-yl)-5-fluoro-N2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine; kinase inhibitors; breast cancer; inhibiting signal transduction cascades in which Syk plays a role
05/11/2010US7713983 Voltage gated sodium and calcium channel inhibitors
05/11/2010US7713979 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
05/11/2010US7713964 Methods for treating asthmatic conditions
05/11/2010US7713963 Acylated indanyl amines and their use as pharmaceuticals
05/11/2010CA2422299C Triazole compounds useful as protein kinase inhibitors
05/11/2010CA2326324C Nitrogen-containing heterocyclic compound
05/06/2010WO2010050779A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
05/06/2010WO2010050191A1 1,2-diazetidin-3-one derivative and pharmaceutical agent comprising same
05/06/2010WO2010049841A1 7-azaspiro [3.5] nonane-7-carboxamide compounds as modulators of fatty acid amide hydrolase
05/06/2010WO2010049449A2 Novel salts of sunitinib
05/06/2010WO2010049233A1 1,3 imidazolidine derivatives and their use in the production of carbapenem
05/06/2010WO2010027746A3 Hedgehog pathway modulators
05/06/2010WO2009155527A9 Phosphatidylinositol 3 kinase inhibitors
05/06/2010US20100113777 INDOLE DERIVATIVES HAVING cPLA2 INHIBITING ACTIVITY AND APPLICATIONS AND PRODUCTION METHODS OF THE SAME
05/06/2010US20100113776 Pyrazole derivative
05/06/2010US20100113549 Pyrrolidine compounds
05/06/2010US20100113546 Imidazol-4-one and Imidazole-4-thione Compounds
05/06/2010US20100113492 Substituted Aminopyrimidines as Cholecystokinin-1 Receptor Modulators
05/06/2010US20100113476 Chemical linkers with single amino acids and conjugates thereof
05/06/2010US20100113468 Quinazoline derivatives as kinase inhibitors
1 ... 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 ... 626